D-Amethopterin; D-Methotrexate; 51865-79-3; (R)-Methotrexate; Methotrexate, (R)-; R-methotrexate; (-)Amethopterin; TCMDC-125488; CHEMBL156; (2R)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid; W12798130R; NSC 117356; Methotrexate, d-; (2~{r})-2-[[4-[[2,4-Bis(Azanyl)pteridin-6-Yl]methyl-Methyl-Amino]phenyl]carbonylamino]pentanedioic Acid; 331717-43-2; EINECS 257-482-2; NSC117356; CAS-59-05-2; UNII-W12798130R; Lopac-A-6770; Lopac-A-9898; D-(-)-N-(2,4-Diamino-6-pteridinyl(dimethylamino)benzoyl)glutamic acid; N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-D-glutamic acid; Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, D-; Lopac0_000095; SCHEMBL171251; d(-)-Amethopterin hydrate,98; CAS-59-05-2-Batch2; R-METHOTREXATE [USP-RS]; DTXSID201317276; ZINC6920406; BDBM50420238; AKOS015895149; CCG-204190; D-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-; D-glutamic acid, N-(4-(((2,4-diamino-6-pteridyl)methyl)methylamino)benzoyl)-; NCGC00015079-01; NCGC00015079-02; NCGC00016264-01; NCGC00016264-02; METHOTREXATE IMPURITY F [EP IMPURITY]; A 9898; A828817; Q27292170; (2R)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid; D-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl][methyl]amino]benzoyl]-; (2R)-2-((4-(((2,4-DIAMINOPTERIDIN-6-YL)METHYL)METHYLAMINO)BENZOYL)AMINO)PENTANEDIOIC ACID; (2R)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid; (2R)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid; 6UV